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Summary
Avian sarcoma virus UR2 is a replication-defective virus that can induce sar­
comas in vivo and transforms chicken embryo fibroblasts in culture to a charac­
teristic, extremely elongated morphology. The genome of UR2 contains a 1.2 kb
transformation-specific sequence, v-ros, which has a homologous counterpart, c­
TOS, in normal chicken cellular DNA. The 5' end of v-ros is fused to the helper
virus UR2AV-related sequencing coding for one of the viral gag proteins, pIg.
The fused pIg and rOB sequences in UR2 code for a polyprotein of 68 kd,
P68gag-ros, which has an associated tyrosine kinase activity. To elucidate the
basis of the functional conservation as well as differences between rOB and other
oncogenes, I sequenced the entire genome of UR2 and compared the predicted
amino acid sequence of P68 with other members of the tyrosine kinase family.
The results show that rOB is 1273 nucleotides in length, including a 65 bp 3'
noncoding stretch. ros is joined at its 5' and 3' ends to the 3' region of p l g, and
the 3' region of gp37, respectively, and replaces the sequences of UR2AV in
between. The deduced amino acid sequence for P68 gives a molecular weight of
61,113 daltons and shows that it is closely related to the oncogene family coding
for tyrosine protein kinases. However, P68 contains two distinctive hydrophobic
regions that are absent in most of the other tyrosine kinases and it has unique
amino acid changes and insertions within the conserved domain of the kinases.
I also determined the sequence of cellular rOB and compared it to viral rOB to
determine the changes between them that may be responsible for their differential
oncogenicity; in addition I have analysed the expression of the cellular gene in
both embryonic and adult chickens. The 1.2 kb v-ros sequence is remarkably
well conserved when compared with the corresponding region of e-ros. The v-ros
sequences are distributed in nine exons of e-ros over a. range of 12 kb of DNA.
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The two differ only by a 9 bp duplication, a single base change not resulting in
an amino acid change, and the divergence of their 3' ends. e-ros and v-ros
abruptly diverge 36 bp upstream of the v-ros termination codon. The open read­
ing frame of e-ros continues after this divergence and may terminate 34 amino
acids downstream, or, more likely, the reading frame is spliced to further 3' cod­
ing sequences using a splice donor site 24 nucleotides downstream of the diver­
gence. The v-ros sequence 3' to the divergence was not found in the 3' e-ros
sequences in the lambda clone or in helper virus-related sequences. Comparison
of the nucleotide sequences of viral and cellular ros suggests the viral ros and
� gag junction in lJR2 was formed by splicing.
A 3.1 kb e-ros transcript has been detected in adult muscle tissue and in kid­
ney from chickens only after long exposure of the Northern filters. It appears
that the e-ros transcript in kidney is preferentially degraded relative to src, and
this may account for the seeming lack of expression in this tissue. In all other
tissues examined, a.nd in several cell lines, e-ros transcripts are not detectable.
Although the exact function of the cellular ros protein is not known, evidence
based on the sequence of the viral and structural genes has enabled us to detect
its structural similarity with the EGF and insulin receptors and postulate that
ros is a mem ber of a family of growth factor receptors.
-viii-
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Section I. Introduction
Oncogenic viruses provide simplified systems to study tumorigenesis and cell
transformation: introduction of the virus into a normal cell is capable of
transforming the cell to a neoplastic state. Tumor viruses may contain RNA or
DNA as their genomes; however, the DNA tumor viruses are diverse and encom­
pass several classes which differ in genomic structure and methods of replication.
The RNA tumor viruses are more unified in their genomic organization and mode
of replication. These viruses replicate through a double-stranded DNA intermedi­
ate synthesized by an RNA-dependent DNA polymerase which is encoded by one
of the viral genes. The more uniform structure and method of replication of the
RNA tumor viruses reduces the number of variables to be considered when study­
ing the mechanisms involved in cellular transformation by this group of viruses.
RNA tumor viruses induce rapid and reproducible transformation of cells in cul­
ture and tumor formation in vivo, and the product(s) encoded by the viral
genome are responsible for the induction and maintenance of the transformed
phenotype. RNA tumor viruses have been isolated from a wide spectrum of ver­
tebrate species, mostly murine, feline and avian. These isolates share many
structural similarities, yet are capable of causing a wide variety of neoplasms in
their respective hosts.
Taxonomy.
Retroviridae (so named for the RNA-dependent DNA polymerase, or reverse
transcriptase) consists of three subfamilies: the oncogenic RNA-containing viruses
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(or oncoviruses), and two non-oncogenic subfamilies. The non-oncogenic subfami­
lies include the Lentiviruses, which produce disease only after prolonged latency,
and the spumaviruses, or foamy viruses, which chronically infect many mam­
malian species without obvious manifestation of disease.
The viral genome of all three subfamilies is composed of a dimer of linear
positive-sense single stranded RNA molecules linked at their 5' ends. The
genome is replicated through a DNA intermediate via the reverse transcriptase
encoded by one of the viral genes. These viruses are enveloped, with glycoprotein
surface projections.
Four categories of oncovirus have been described by morphological
classification of physical structure in electron micrographs: A-, B-, C-, and D-type
particles. Most oncoviruses have been classified as type C, and can be divided
into two categories: leukosis viruses with low oncogenic potential, and leukemia
and sarcoma viruses with high oncogenic potential. Both kinds of virus have
been isolated from murine, feline, avian and primate species, but this discussion
will be restricted to viruses of avian origin.
Lymphoid leukosis viruses (LL Vs).
Avian leukosis virus (of which the Rous-associated viruses, RAV-l and RAV-
2, and the UR2-associated virus, UR2AV, are examples) does not transform
chicken cells in culture, and induces tumors, mostly lymphomas, in vivo only
after a long latency period of three to four months after infection of chickens.
The disease originates primarily in the bursa. Infected birds may show prolifera­
tion of immature red blood cells, and/or infiltration of neoplastic cells into the
liver or spleen.
The genome is composed of three genes important for viral replication: gag,
pol, and env, as well as the long terminal repeat regions, or LTRs (Fig. 1). The
Fig. 1. Genome of ALV. The upper lines show the terminal regions expanded
as indicated. The precursor protein is shown as a solid bar underneath the
genome, and the molecular weights of the processed proteins are indicated. L,
gag, pol, and env are defined in the text.
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ALV genome is bounded on its 5' end by a cap, and a short sequence, R, which is
repeated at both the 5' and 3' ends of the RNA. The binding site for the initia­
tion of the tRNA primer (PB) for negative-strand DNA synthesis follows the
region denoted U5. The gag gene is 2.1 kb in length and codes for the internal
structural proteins of the virion, which are first synthesized as a 76,000 dalton
precursor (Pr76gag) from the 35S genomic RNA. Pr76 is subsequently cleaved by
proteolysis to several lower molecular weight gag proteins. The genomic order of
these proteins is H2N-p19-plO-p27-pI2-pl5-COOH. The gag gene is preceded by
an untranslated sequence (L) of approximately 250 nucleotides which is part of
the 5' 380 nucleotide leader sequence that is spliced to the subgenomic mRNAs.
The L region may include sequences important for RNA packaging. The pol gene
has a length of 2.7 kb and codes for the reverse transcriptase, which is syn­
thesized as a gag-pol precursor, Pr180, from the 35S genomic RNA (or an as yet
unidentified spliced mRNA). Pr180 is cleaved to produce a 92,000 dalton
polypeptide known as /3 which is subsequently cleaved into the 58,000 dalton a,
and 32,000 dalton p32, proteins. The reverse transcriptase is composed of a and
f3 subunits. A DNA endonuclease activity was found to be associated with p32
and is proposed to be involved in the process of viral DNA integration. The env
gene codes for the glycoproteins coating the surface of the virion. Unlike gag,
which is translated from 35S genomic RNA, env is translated from a 22S
subgenomic mRNA. The primary env product, a 57,000 dalton protein, is
glycosylated to form the precursor, gPr92env which is later cleaved into two
polypeptides, gp85 and gp37. The region immediately preceding U3 contains a
polypurine tract (pp) believed to be important for initiation of positive-strand
DNA synthesis. U3 precedes the 3' terminal repeat region, R, and contains pro­
moter sequences necessary for transcription of the genome. During replication of
the viral RNA to form proviral DNA, U3 and U5 are duplicated to form the LTR
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(consisting of U3-R-U5) which appears at each end of the provirus.
After nonspecific adsorption of the virus to the host cell surface, a penetra­
tion step follows that is dependent on the envelope glycoproteins of the virus and
on specific cell receptors. A cellular tRNA acts as primer by binding near the 5'
end of the genome (PB) and initiating synthesis of (-) strand DNA. Concommi­
tant synthesis of (+) strand DNA yields a double stranded linear provirus. The
reverse transcriptase coded by the pol gene is responsible for the synthesis of the
DNA intermediate. Duplication of the U3 and U5 regions during DNA synthesis
leads to formation of the LTRs. The linear DNA is synthesized in the cytoplasm;
after transport to the nucleus, a population of the linear molecules is converted
to a closed circular form. Recent work by Panganiban and Temin (48) has shown
that the 5 bp terminal inverted repeats at the ends of the LTRs from unin­
tegrated linear DNA, as well as 3-7 adjacent nucleotides, are required for integra­
tion. After integration into the host genome, the provirus will replicate with the
cellular DNA (Fig. 2). Transcription of the proviral template yields RNA that
can be packaged and released by budding as infectious virions after assembly on
the cell membrane. However, integration of the retrovirus DNA is not absolutely
required for retroviral gene expression of the spleen necrosis virus(48).
The leukosis viruses do not contain oncogenic sequences. However, these
viruses may become acutely transforming by transduction of cellular sequences,
now known as proto-oncogenes or cellular oncogenes. These cellular genes
acquired by the retrovirus are called viral oncogenes. Acquisition of the viral
oncogene usually involves the sacrifice of some of the viral replicative genes, so
that the newly-derived acutely transforming virus needs the parental leukosis
virus as "helper" to replicate.
- B -
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Fig. 2. Structure of retroviral RNA and proviral DNA. R, terminal
redundancy on genomic RNA; U5 and U3, sequences unique to the 5' and 3' ends
of the genomic RNA; LTR, long terminal repreat.
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Acutely transforming viruses.
Rous sarcoma virus, isolated in 1910 by Peyton Rous, was the first retrovirus
later found to contain a genetic sequence essential for neoplastic transformation
that was independent of the genes necessary for viral replication. The transform­
ing sequence of RSV, known as src, is inserted in nondefective strains of the virus
between env and the LTR, and the resulting virus retains all the replicative func­
tions (Fig. 3). (In Fig. 3, all viruses shown are presented as the proviral DNA
intermediate.) In some isolates of RSV, e.g. the Bryan high-titer strain, src has
replaced env and the virus then requires an associated leukosis virus to provide
replicative functions in trans. Although the nondefective strains of RSV were at
one time considered to be prototypical of the sarcoma viruses, they have turned
out to be exceptional among all known acutely transforming retroviruses in that
acquisition of the src sequences has not been at the expense of some of the viral
replicative genes. The ere gene product is translated from a subgenomic mRNA
and encodes a 60,000 dalton phosphoprotein, pp60src. With the help of src dele­
tion and temperature-sensitive mutants, coupled with transfection of src DNA, it
was demonstrated that both in vitro cell transformation and in vivo tumorigeni­
city of RSV require a functional src product. pp60src is phosphorylated on serine
and tyrosine, and has been shown to have tyrosine kinase activity. Phosphotyro­
sine is extremely rare in normal cells, but cells transformed by RSV have a 10-
fold elevated level of phosphotyrosine (58). It is believed that transformation by
RSV is dependent on the tyrosine kinase activity of pp60src.
In 1976, Dominic Stehelin experimentally demonstrated the presence of cellu­
lar sequences in chicken related to viral src (66). Later studies showed that src­
related sequences are present in fish, birds, mammals, and even Drosophila, indi­
cating these sequences have been highly conserved during evolution, The gene
product of the ere cellular homologue was identified in normal chicken cells as a
- 8 -
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Fig. 3. Genomic structure a representative member of each class of
avian sarcoma virus. UR2AV, the UR2-assoclated virus, Is shown to compare
the structure of an avian leukosis virus with the ASVs. All viruses are shown as
the proviral DNA form. UR2, University of Rochester viral isolate number 2;
FSV, Fujinaml sarcoma virus; Y73, Yamaguchi-73; and SR-RSV, Schmidt-Ruppln
strain of Rous sarcoma virus. ros, Ips, yes, and STC (denoted by jagged line) are
the transforming genes of UR2, FSV, Y73, and RSV, respectively.
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cells as a 60,000 dalton phosphoprotein which also has tyrosine kinase activity;
the viral and cellular proteins are highly homologous.
RSV and its derivatives were thought to be the only avian sarcoma viruses
until 1980, when the Fujinami sarcoma virus was shown to contain a transform­
ing gene distinct from src (24, 33). This was originally shown by partial sequence
analysis of FSV RNA by oligonucleotide fingerprinting. The transforming
sequence of FSV is now known as Ips. Several viruses which have independently
transduced portions of the cellular Ips gene have been isolated and include FSV,
PRClI, PRCIV, 16L, and URI. It appears that [es, the transforming sequence of
the Snyder-Theilen and Gardner-Arnstein strains of feline sarcoma virus, is the
feline homologue of avian Ips (59).
Acquisition of Ips by FSV has led to the loss of the 3' region of gag and the
entire pol and env genes (Fig. 3). FSV encodes a 140,000 dalton gag-fusion pro­
duct that also has an associated tyrosine kinase activity.
A third class of avian sarcoma virus is comprised of viral isolates that have
acquired the transforming sequence known as yes, and includes the Yamaguchi 73
(Y73) and Esh sarcoma virus (ESV) strains. Y73 encodes a 90,000 dalton phos­
phoprotein, P90, which, like FSV P140, has 5' gag sequences fused to the amino­
terminus of the specific sequence.
The fourth and most recently characterized class of avian sarcoma virus IS
the UR2 virus, so called because it is the University of Rochester avian sarcoma
virus isolate number two. UR2 was originally isolated with its associated helper
virus, UR2AV, in 1963 from a fibrosarcoma of a 9 month old White Rock chicken
(4). UR2 has lost most of both the gag and env genes and all of the pol gene dur­
ing acquisition of ros (Fig. 3). UR2 is able to induce sarcomas in chickens and
efficiently transform chicken embryo fibroblasts (CEF) in culture (4). CEF
transformed by UR2 are characterized by an extremely elongated morphology (4).
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Fig. 4 shows the characteristic UR2 transformed morphology, relative to the
refractile, rounded morphology of cells transformed by two strains of RSV,
Schmidt-Ruppin and B77. Previous analysis of the UR2 RNA genome showed
that it shares with its associated helper virus, UR2AV, about 2.1 kb of 5' and 3'
sequences and contains at the middle of the genome about 1.2 kb of ros-specific
sequence (82). Studies of the ros sequence by hybridization and oligonucleotide
fingerprinting have shown that it is distinct from the transforming genes of other
known ASVs and acute leukemia viruses (61, 82). The normal cellular DNA
homologue of viral-res has been detected in chickens, quail and ducks (61). How­
ever, the expression of e-ros in various tissues and organs of 10- to 14-day old
chickens is very low (less than 1 copy per cell), except in the kidney (2.5 copies
per cell) (61).
The UR2-infected cells produced only 24S genomic RNA (82) which was
shown to encode for a 68,000 dalton gag-ros fusion protein, P68, that was associ­
ated with a tyrosine-specific protein kinase activity (17) (Fig. 5). The enzymatic
properties of P68 are distinct from other ASV protein kinases, i.e., Rous sarcoma
virus (RSV) p60, Fujinami sarcoma virus (FSV) P140, and Y73 ASV P90, in
cation preference, pH optimum, and phosphate donors (17). Similar to other
ASV-transformed cells, organization of microfilament bundles in UR2-transformed
CEF is significantly decreased compared to uninfected cells (2). A common
feature of most of the acutely transforming viruses exemplified by three classes of
avian sarcoma virus shown in Fig. 3 is that the acquired cellular sequences are
fused to viral sequences, in these cases, gag, to form a fusion polypeptide. All
virus isolates described thus far in the literature which have acquired either Ips,
yes, or ros are replication-defective.
In addition to the sarcoma viruses, it was shown that certain avian leukosis
viruses, for example, AMV (avian myeloblastosis virus), AEV (avian erythroblas-
IFig. 4. Transformation of CEF in culture by ASV. CEF, uninfected
chicken embryo fibroblasts; B-77 and SR-RSV, CEF transformed by the Bratisla­
va or Schmidt-Ruppin strains of RSV; UR2, CEF transformed by UR2.
CEF
SR RSV
UR2 ASV
B77 ASV
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UR2
24 S
RNA
P68
Fig. 5. Production of P6sgag-ro8 from UR2 proviral DNA. The
integrated provirus is transcribed into 24S RNA, which is translated to yield P68.
�gag, ros, and � env are defined in the text.
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tosis virus), and MC29, have also acquired cellular proto-oncogene sequences that
permit the rapid induction of leukemias in vivo and the transformation of specific
hematopoietic cells in vitro. These acute leukemia viruses are defective for repli­
cation as well, due to the loss of viral replicative sequences during transduction of
the proto-oncogene.
Scope 01 this thesis.
Clearly, ros is a member of the retroviral oncogene family coding for
tyrosine-specific protein kinases, despite differences in nucleotide sequences among
these genes. In order to understand the basis for similarities and differences in
the transforming functions of ros and other oncogenes, a detailed analysis of the
genetic structure of UR2 and ros sequence is necessary.
I have molecularly cloned the full-length genomes of UR2 and UR2AV. Both
were shown to be biologically active. Cross-hybridization among ros and three
other ASV transforming genes (src of RSV, Ips of FSV, and yes of Y73 ASV),
showed that ros shared some sequence homology with Ips, and little or no homol­
ogy with src and yes. I have also sequenced the entire genome of UR2 and com­
pared the predicted amino acid sequence of PBS with other members of the
tyrosine-specific protein kinase family. This work will be detailed in Section III.
The strong evolutionary conservation of most viral oncogenes and the fact
that several of the cellular oncogenes are expressed in both embryonic and adult
tissues suggests they play an important role in growth and/or differentiation of
normal cells. Intensive characterization of known oncogenes has in a few cases
enabled us to infer their function in the normal cell; for example, sis, an oncogene
transduced by a simian retrovirus, appears to code for part of the platelet-derived
growth factor. erbB, an oncogene of avian erythroblastosis virus, appears to
represent part of the EGF receptor. In the majority of cases, however, little is
- 14 -
known about the normal function of the cellular proto-oncogene, and what
changes during or after acquisition of the oncogene by the virus confer transform­
ing ability to these genes. It is possible that transformation by retroviruses is
dependent on the sustained and abundant expression of the oncogene, or that
mutation of the viral oncogene during transduction by the virus in some way
effects transformation.
To address these fundamental questions, I have analysed the structure and
expression of the chicken cellular homologue of viral ros. The cellular and viral
ros genes appear to have been highly conserved during transduction of the
specific sequence by the virus and subsequent passages of the virus in culture. In
addition, the cellular ros locus is under very tight developmental control. This
work is described in Section IV.
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Section ll. Materials and Methods
Cells and viruses.
The preparation of CEF, UR2, and the subgroup A UR2-associated virus
(UR2AV) followed the published procedure (4, 82). A methylcholanthrene­
transformed quail cell line, QT6 (42), was cultured similarly to CEF.
Isolation of closed circular proviral DNA.
A pilot experiment was performed to determine conditions for maximal yield
of unintegrated circular proviral DNA for cloning. QT6 or CEF cells were seeded
at 5 x 106 cells per dish and infected with 5 ml of UR2(UR2AV) containing
medium from transformed CEF cultures in the presence of 17 ug per ml DEAE­
dextran. Medium was replaced 5 h later. 6 10 ern dishes each (approximately 5 x
10
7
cells) of UR2(UR2AV)-infected QT6 or CEF were harvested at 24, 48 and 72
hour timepoints. At each timepoint, total cellular DNA was isolated by the Hirt
procedure (25), and 20 ug of the Hirt supernatant DNA containing unintegrated
provirus was electrophoresed through a 0.8% agarose gel, blotted to nitrocellulose
paper, and probed with 32p cDNA made from 24S UR2 RNA. The highest yield
of proviral DNA was obtained from UR2(UR2AV)-infected QT6 cells harvested
24 h after infection. Therefore, QT6 cells were seeded as described above and
infected with UR2(UR2AV) at a multiplicity of one in the presence of DEAE­
dextran and were harvested 24 h postinfection. After Hirt precipitation, the
DNA in the supernatant was extracted with phenol-chloroform and concentrated
by ethanol precipitation. The DNA was further purified by treatment with
RNase A, additional phenol-chloroform extraction, and ethanol precipitation. To
enrich for closed circular DNA, the DNA was then extracted with acid-phenol as
- 16 -
described by Zasloff (86). A yield of 960 ug of DNA was obtained from a total of
95 8.5-cm dishes after acid-phenol extraction and were applied to a Bio Rad A5m
(100-200 mesh) gel column to remove small (less than 1 kb), contaminating linear
DNA fragments. The column was washed and the DNA was eluted with a buffer
containing 20 mM Tris-HCI (pH 7.2), 0.1 N NaCI, and 5 mM EDTA. A total of
20 ug of closed, circular DNA were recovered in the peak fractions.
Molecular cloning and subcloning of UR2 and UR2A V DNAs.
One ug each of EcoRI- or BstI-cut UR2 and UR2AV closed circular proviral
DNAs were ligated to two ug of AgtWESAB (32) EcoRI or BstI arms, respectively.
One ug of the ligation mix was packaged in vitro into lambda phage particles (32,
62). Lambda arms were purified from the internal fragment by sucrose gradient
centrifugation (36). The recom binant phages were titered on E. coli ED8654 (44).
Packaging efficiencies of 2.6 x 105 and 8 x 103 plaque forming units (pfu) per ug
of DNA were obtained for the BstI and EcoRI cut and ligated DNAs, respectively.
Screening of the recom binant phages with 32P-Iabelled cDNA made from 24S
UR2 RNA was according to the procedure of Benton and Davis (6).
Subcloning of the EcoRI insert from the UR2-lambda recombinant phage
clone into pBR322 was according to Bolivar et. al. (8). The UR2 plasmid clone
was called pUR2. Similarly, a 850 bp EcoRI - Pvull v-ros specific DNA fragment
was cloned using the 2293 bp Pvull - EcoRI fragment of pBR322 DNA. This
clone was called p rosl.
A recombinant clone containing cellular sequences homologous to v-ros was
previously isolated by Masaburni Shibuya in our laboratory from a library com­
posed of AluI- and HaeIII-partially digested chicken genomic DNA cloned in
Charon 4A with EcoRI linkers (15). The three EcoRI fragments comprising AC­
ros were freed from the lamda vector DNA and subcloned into the EcoRI site of
- 17 -
pBR322. E. coli C600 cells (3) were used for all transformations.
Transfection of cloned UR2 and UR2A V DNAs .
The UR2 and UR2AV DNAs were freed from the vector DNAs by restriction
enzyme digestion and were purified by agarose gel electrophoresis. They were
transfected without prior ligation onto CEF using the calcium phosphate method
(22) with the following modifications. One ug each of UR2 and UR2AV DNA
were mixed with with salmon sperm DNA to a total of 20 ug and added to 500 ul
of 20 mM HEPES (pH 7.0), 137 mM NaCI, 5 mM KCI, 0.59 mM Na2HPO4'
One-tenth volume of 1.25 M CaCl2 was added and the mixture was allowed to sit
at room temperature for 15 minutes. The solution was then added to cells in 5
ml of growth medium and the culture was incubated at 37°C. The cells were
seeded one day before at 7 x 105 cells per 6 ern plate. Medium was changed five
hours after the addition of viral DNAs. The cells were transferred to 8.5 em
dishes as they became confluent and overlayed with soft agar medium the next
day to enhance the growth of transformed cells. Virus production was assayed
by determining the presence of reverse transcriptase activity in the supernatants
of transfected cells (80).
Protein analysis.
UR2/UR2AV transfected cells grown III 6 crn dishes were labeled with 500
uCi per plate of [35S]-methionine for 5 h. Extraction of cold or 35S-labeled cellu-
lar proteins, irnmunoprecipitation, protein kinase assay and sodium-dodecyl sul-
fate (SDS)-polyacrylamide gel (5 to 15%) electrophoresis followed the described
methods (16). Anti-gag serum and sera from RSV-infected tumor bearing rabbit
(TBR) were kindly provided by Ricardo Feldman.
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Rl\/A isolation, bloitinq and hybridization.
Total cellular poly(A}-containing RNAs from UR2AV and CR2/UR2AV DNA
transfected cells were isolated according to the described procedures (81, 83).
The RNAs were denatured with glyoxal, separated on 1 % agarose gels,
transferred to nitrocellulose paper (81, 83), and hybridized to a 5' probe contain­
ing the "leader" sequence (see below), and to a probe derived from the 850 bp
ros-specific DNA described above. Conditions for hybridization and washing of
the filters have been described previously (81).
Polyadenylic acid-containing RNAs were isolated from brain, eye, stomach
and intestine, heart, and liver of 12, 14, 16, 18, and 20 day chicken embryos and
2 day and 7 day old chicks; from lung tissue of 18 and 20 day embryos and 2 day
and 7 day old chicks; from extraembryonal membranes at all embryonic
timepoints described above; from kidney of 20 day embryos and 2, 4, 7, 10, 14,
21, 28, and 56 day old chickens; and from muscle tissue of all embryonic and
adult timepoints described above. Tissues were removed from freshly-killed birds
and frozen by immersion in liquid nitrogen, and were stored at _700 C. Alterna­
tively, the tissue was immediately suspended in a solution containing 5 M guani­
dine thiocyanate, 25 mM Tris-hydrochloride (pH 7.0), 10 mM dithiothreitol, 1 %
sarkosyl, and 5 mM EDTA and homogenized at high speed in a Waring blender
for two 3D-second pulses. Unbroken tissue debris was removed by low speed cen­
trifugation. The clear homogenate was layered on top of a solution containing
5.7 M CsCI and 0.1 M EDTA (pH 7.0) and centrifuged at 26,000 rpm for 18 hr.
The RNA pellets were resuspended in 10 mM Tris-hydrochloride (pH 7.2), 10 mM
NaCI, 1 mM EDTA, and 0.05% SDS, extracted with phenol-chloroform and
ethanol precipitated. PolY(A}-positive RNAs were twice selected and electro­
phoresed as described above. The Northern blots were hybridized to the 850 bp
ros-specific DNA and to a 3' src-specific probe (described below).
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Preparation of
32P-labeled DNA probes.
24S lTR2 and 35S UR2AV RNA was isolated from purified virus as described
previously (79, 80), twice poly(A}-selected and used separately as templates in the
in vitro reverse transcriptase reaction. The 200 ul reaction mixture contained 50
mM Tris-HCI (pH 8.0), 40 mM KCl, 4 mM MgC12, 2 mM DTT, 200 uM each
dATP, dGTP and TTP, 60 ug of calf thymus DNA primers (72), 20 ug
Actinomycin D, 300 uCi (3000 Ci/mmole) [ 32p]_dCTP, 150 units avian myelob­
lastosis virus reverse transcriptase (provided by J. Beard, Life Sciences, St.
Petersburg, Florida, through the courtesy of J. Gruber, the Resource Program,
National Cancer Institute), and 0.3 ug of template. The reaction mixture was
incubated at 37
0
C for 2 h, and the reaction was quenched by the addition of a
solution containing 0.5 M LiCI, 10 mM Tris-Hel (pH 7.2), 10 mM EDTA. and
0.2% SDS. After ethanol precipitation, the sample was base-hydrolyzed with 0.2
N NaOH containing 1 mM EDTA at 100
0
C for one hour, neutralized, and passed
through a Sephadex G-50 column. The DNA from the void volume fractions
were precipitated in ethanol.
Probe containing 80-90% ros-specific sequences was made by annealing
cDNAUR2 to total chicken embryo fibroblast RNA and to viral RNA isolated
from cells infected with UR2AV to remove cDNAs unrelated to ros using the pro­
cedure described by Shibuya et. al. (62).
Preparation of the following probes specific to various regions of the genome
of the Schmidt-Ruppin strain of RSV was as described (83). The 5' probe is a
500 bp long fragment spanning the EcoRI site within the U3 region of the left­
hand long terminal repeat (LTR) to the BamHI site in the 5' gag region; the 5'
gag probe is 1.3 kb and spans the two Bam HI sites within the gag region; and
the 3' gag probe spans the second BamHI site in gag to the downstream EcoRI
site and is 400 bp in length. pol and pol-env probes were prepared from pSR2
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(13). The pol probe is 1.45 kb and spans the HindIII to BglII site in pol; the pol­
env probe is 1.8 kb, extends from the BglII site in pol to the EcoRI site in env,
and covers the 3' portion of pol plus more than 1 kb of env sequence. The c
probe covers the 450 bp extending from the Pvull to the EcoRI site in the U3
region of Schmidt-Ruppin B.
A probe specific to 3' v-fp« was derived from pBRF04, a plasmid containing a
400 bp BamHI DNA fragment from FSV Ips (62). The 3' v-yes probe used was
the 1.1 kb Pstl fragment from Y73 (29), and the 3' v-src probe used was a 900 bp
Pvull fragment from pTT107 (68). Two ros-specific probes were used: one was
the 850 bp EcoRI - PvuII fragment which covers the 3' two-thirds of ros, and the
other was an internal ros sequence, the 300 bp A val D fragment (Fig. 14).
Restriction mapping.
Two approaches were employed. In the first approach, end-labeled DNAs
were used for mapping. UR2 DNA isolated from EcoRI cleaved pUR2 was
labeled at its 5' end with 32p using T4 polynucleotide kinase (BRL) after diges­
tion with bacterial alkaline phosphatase (BRL). UR2AV DNA from one of the
recom binant clones was isolated from its lambda vector by digesting with Sst!.
The 3' protruding Sst! ends were labeled using 3'-dATP ([ 32P]-cordycepin 5' tri­
phosphate, NEN) and terminal transferase (NEN) according to the conditions
provided by the manufacturer. The end-labeled DNAs were digested with a
single-cut enzyme to generate two fragments of unequal size, each containing a
single 32P-Iabeled end. These fragments were subjected to various restriction
enzyme digestions, aliquots containing 104 cpm DNA were removed 3 min, 6 min,
10 min, and 60 min after initiation of the reaction and stopped by addition of
EDTA to 10 mM followed by heating at 650 C for 3 minutes. About 5000 cpm of
each restricted, end-labeled fragment were electrophoresed through 5%
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acrylamide and 1.4% agarose gels using 32P-Iabeled HindIII-digested lam bda
DNA and Hinjl-digested pBR322 DNA as markers. The gels were dried on DE81
paper (Whatman) and exposed for 8 to 12 hours with an intensifying screen
(Cronex). In this manner, the order of restrictions sites from the labeled end
could be precisely mapped.
In the second approach, cold UR2 and UR2AV DNAs were digested with the
same set of enzymes used for partial mapping, electrophoresed through 0.8%
agarose gels and blotted onto nitrocellulose (65). The approximate gene boun­
daries were determined by hybridizing the blots with 2 - 5 x 105 cpm of the
gene-specific probes mentioned above. Hybridization and washing conditions
have been described elsewhere (61).
Enzymes were purchased from NEB or BRL.
Hybridization of v-ros to 3'-specific v-onc probes.
UR2 DNA was digested with enzymes that cut within ros, generating 5'- and
3'-ros specific fragments, which were blotted and hybridized to 2 x 106 cpm of
probe under low (35% formamide, 5X SSC) or moderate (50% formamide, 3X
SSC) stringency at 370 C for 2 days (IX SSC equals 0.15 M NaCI and 0.015 M
Na citrate ). Washing conditions for moderate stringency hybridizations were
similar to those described before (61); for low stringency conditions, blots were
washed 3 times for 20 min each in 300 ml of 26 mM Tris-HCI (pH 7.4), 2X ssc, 1
mM EDTA and 0.1% SDS at 550 C followed by a similar wash at 600 C. For
sequential hybridization, the previous probe was eluted at 680 C in 40 ml of 50%
formamide, IX SSC, 50 mM Tris-HCI (pH 7.4), 1 mM EDTA and 0.1% SDS.
The blot was exposed to an X-ray film overnight to determine the extent of elu-
tion.
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Heteroduplex mapping.
In collaboration with Ming-Ta Hsu at this University, heteroduplex mapping
of the e-ros clone with pUR2 was performed and visualized by electron micros­
copy.
DNA sequencing.
plJR2 was used for nucleotide sequencing of the UR2 genome. The DNA
sequence was determined by the methods of Maxam and Gilbert (39) and Sanger
(55). For dideoxy sequencing, DNA fragments from pUR2 (Fig. 14) were sub­
cloned into the EcoRI site of M13mp8 (41) with EcoRI linkers (Fig. 16). M13mp8
recom binant clones of both polarities were sequenced at least twice by the
dideoxy method.
The DNA sequence of the introrr/exon boundaries and exons in )..c-ros as well
as the 1.4 kb of 3' noncoding sequence in the recombinant clone was determined
by the method of Sanger (55). DNA fragments (Fig. 23) from the c-ros clone
were gap-filled and blunt-end ligated into the SmaI site of M13mp8 (41) (Fig. 23).
Hydrophilicity analysis.
The hydrophilicity profile of the 4�amino acid TOS region of P68gag-ros was
determined by using the computer program of Hopp and Woods (26) with the
hydrophilicity values for each amino acid determined by Levitt (35).
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Section ID. Results
(v-ros)
Restriction enzyme analysis of circular UR2 and UR2A V DNAs.
In general, although the total yield of DNA from UR2(UR2AV)-infected CEF
was greater at all three timepoints than the DNA yield from infected QT6 cells,
Southern hybridization analysis revealed a higher proportion of UR2 and UR2AV
proviral DNAs from infected QT6 cells (Fig. 6). The DNA does not migrate as
discrete bands. This may be due to the presence of degraded viral DN.As, which
would be detected by the hybridization probe. Contaminating cellular DNA and
protein might not have been completely excluded by the Hirt procedure and
might also have contributed to the anamolous pattern of migration. Maximal
yield of material hybridizing to the viral-specific probe was obtained 24 hours
postinfection from UR2(UR2AV)-infected QT6 cells. Linear UR2AV proviral
DNA migrates at approximately 8 kb, and the circular form of the UR2AV pro­
virus migrates more rapidly at 4.3 kb. The ratio of linear to circular DNA is 1:1.
However, UR2 linear and circular molecules are not clearly seen, indicating a
higher ratio of L'R2AV to UR2 molecules.
DNA from all timepoints was pooled and further enriched for circular DNA
by acid-phenol extraction. Approximately 25% of DNA recovered from the aque­
ous phase was analysed by Southern hybridization with a probe representative of
the UR2 genome, cDNAUR2' which includes UR2AV-derived sequences (Fig. 7A),
or to a ros-specific probe (Fig. 7B). Probe containing sequences common to UR2
and UR2AV detected the UR2AV circular DNA doublets containing one or two
LTRs migrating at 4.3kb as well as the corresponding two species of UR2 circular
DNA migrating at 2 kb. There is no evidence of the linear forms, which would
migrate at 8 kb for UR2AV and 3.5 kb for UR2, indicating a
�
Fig. 6. Isolation of proviral UR2 and UR2AV DNA. UR2(UR2AV)­
infected chicken embryo fibroblasts (CEF) or QT6 cells were harvested 24, 48 or
72 hours post infection. Proviral DNA was isolated from the Hirt supernatant,
and 20ug from each timepoint was electrophoresed through a 0.8% agarose gel,
blotted onto nitrocellulose paper and probed with [32p]cDNA made from 248
UR2 RNA.
CEf QT6
I I I I
kb 24 48 72 24 48 72 hours postinfection
2.2-
1.9-
-UR2AV linear
-UR2AV circular
Fig. 7. Enrichment for circular proviral DNA. Proviral DNA from the
timepoints in Fig. 6 were pooled and extracted with acid phenol. 25% of the
recovered aqueous phase was loaded onto a 0.8% agarose gel, blotted onto nitro­
cellulose, and probed with cDNAUR2 (A) or cDNAros (B).
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high degree of enrichment for the circular
form after acid-phenol extraction.
Unintegrated viral DNA isolated from UR2(lJR2AV)-infected QT6 cells was
subjected to digestion by various restriction enzymes to determine which endonu­
cleases cleaved at a single site and thus would be suitable for cloning. Fig. 8
shows the results of such analysis. They indicate that KpnI, BstJ, and XhoI each
cleaves both UR2 and UR2AV DNAs at a single site. The linearized UR2AV
DNA doublet bands at 8.0 kb and the linearized UR2 doublet at 3.5 kb. These
sizes compare well with previous estimates by electrophoretic analysis of UR2 and
UR2AV viral RNAs (82). BamHI cleaves UR2AV DNA several times, and UR2
DNA once. The HindIII pattern indicates at least one recognition site in both
UR2 and UR2AV; however, the presence of partially-digested DNA obscures
further analysis. Ball does not cut either UR2 or UR2AV DNA. The doublet
migrating at 9.5 kb after Ball digestion most likely represents randomly nicked
circles, and could also be seen after incubation of the circular proviral DNA in
restriction enzyme buffer with no enzyme added.
To remove the small, contaminating linear DNAs (most likely representing
degraded viral DNAs) visible in each lane, the large preparation of proviral DNA
for cloning was further purified by chromatography through an A5m gel column
after acid-phenol extraction. The restriction patterns of EcoRI and BstI diges­
tions of the purified circular DNAs are shown in Fig. 9. BstJ cuts UR2 and
UR2AV DNAs each only once, and the linearized viral DNA containing either one
or two copies of the LTR run at positions corresponding to about 3.5 kb for UR2
and 8.0 kb for UR2AV. EcoRI cleaved UR2 DNA once, liberating the linearized
UR2 DNA, but cut UR2AV DNA three times, releasing several subgenomic frag­
ments. The majority of the acid phenol- and column-purified viral DNAs
appeared to be of the circular forms. However, the majority of the DNA prepara­
tion was of cellular origin, because the viral DNA could be detected only by
Fig. 8. Restriction enzyme analysis of circular UR2 and UR2AV DNAs.
20 ug of partially-purified proviral circular DNA was digested with the indicated
enzyme, electrophoresed through a 0.8% agarose gel, blotted onto nitrocellulose
and probed with cDNAUR2.
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Fig. 9. Restriction enzyme analysis of isolated circular UR2 and
UR2AV DNAs. 5 ug of material containing unintegrated proviral DNA were
restricted with either SstI or EcoRI, and 2 ug of each digest were loaded per well,
electrophoresed through a 0.8% agarose gel, blotted onto nitrocellulose papers,
and probed with [32p)cDNA made from 248 UR2 RNA.
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hybridization to the cDNA probe, and not by ethidium bromide staining of the 2
ug of DNA loaded per well in the agarose gel.
Molecular cloninq of UR2 and UR2A V DNAs.
Remaining DNA from the EcoRI and SstJ digests described above were used
for cloning, using purified )...gtWES)"'B EcoRI and SstI arms. cDNA probe made
from 24S UR2 RNA was used for the screening. Eight full length helper viral
DNA clones were obtained using the SstJ site for the cloning. Eleven )...UR2AV
recombinant phages, each containing more than one UR2AV EcoRI fragment,
and a )...UR2 clone were isolated using the EcoRI site for cloning. About 0.15%
(12 clones out of 8000 plaques screened) of the recombinant phages contained
viral sequences using EcoRI arms of the lambda DNA for the cloning.
The number of UR2AV clones isolated was roughly tenfold the number of
UR2 clones. This can be expected from the ratio of UR2AV to UR2 DNA as
shown in Figs. 7, 8 and 9. This probably reflected the ratio of the helper to the
UR2 virus in the stock used for the infection of the QT6 cells. This has been
previously observed in several UR2(UR2AV) virus stocks (4). Additionally, the
packaging efficiency of the lambda vector for fragments the size of the UR2
genome IS quite low. Each UR2 and UR2AV lambda recombinant phage clone
was purified by 3 to 4 cycles of single plaque isolation.
To confirm the identity of the UR2 clone, the viral DNA insert was hybri­
dized with probes specific to various regions of the RSV genome according to the
procedure of Southern (65). As expected, the UR2 DNA hybridized only to the
5', 5' gag, and c probes in addition to the cDNA made from UR2 genomic RNA,
but not to pol and pol-enu probes. It has been previously determined (82) that
the pol gene is deleted and the gag and env genes are truncated in the UR2
genome. Because the size of the insert from this recombinant clone, 3.4 kb, is
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equivalent to that determined for the UR2 genomic RNA (82), it is most likely
that this clone contains a full-length copy of the UR2 genome. However, this
clone contained, in �ddition to the 3.4 kb UR2 insert, a tandemly linked 3.7 kb
DNA fragment of non-viral sequence. Therefore, the 3.4 kb UR2 DNA was
purified and subcloned into the EcoRI site of pBR322. All further studies of the
UR2 genome were done with this recombinant plasmid clone, called pUR2.
Transfection assays of UR2 and UR2A V DNAs.
Insert DNAs isolated from plJR2 and from one of the UR2AV lambda clones,
4B2, were introduced together onto CEF. The transfected cells displayed typical
UR2 transformed elongated morphology and produced UR2(UR2AV) pseudotype
virus about two weeks after transfection. This demonstrated that both UR2 and
UR2AV clones tested were biologically active. In addition, 5 independently iso­
lated UR2AV-Iambda clones (A2I, Dl, IC-l, 4-1, 14-1) were cut with SstI to free
the insert from the lambda DNAs, and were introduced similarly onto CEF.
Assays for reverse transcriptase activity in the culture fluid of transfected cells 10
days post transfection were positive for all but clone 1 C-l. The map of the
UR2AV DNA insert of clone lC-I was identical to that of 14-1, which was biolog­
ically active, except that the lC-l insert was missing a portion of the SstI - Hin­
dIll right-hand region (see Fig. 13 for the restriction sites). This region contains
the LTR and deletion of this segment might account for the loss of biological
activity.
To confirm that the transformation was induced by UR2, total poly(A)­
containing cellular RNA was isolated from the transfected cells, and analysed by
RNA blotting and hybridization. Fig. 10 shows that the transfected cells display
a subgenomic and genomic RNA pattern identical to that of UR2(UR2AV)­
infected CEF. Hybridization of the RNAs to the 5' probe detected 358 genomic
'-
Fig. 10. RNAs of UR2 and UR2AV DNA transfected CEF. 10 ug of
poly(A)-containing RNAs isolated by SDS-proteinase K extraction of UR2 and
UR2AV transfected cells were denatured with 1 M glyoxal and fractionated on
1 % agarose gels. The RNAs were transferred to nitrocellulose paper and hybri­
dized with a 5' leader or ros-specific probe. RNAs isolated from UR2(UR2AV)­
infected cells were used as controls. 32P-Iabeled HindIII cut lambda DNA was
denatured and run is parallel for molecular weight markers.
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RNA and 22S subgenomic envelope mRNA of UR2AV, as well as the 24S
genomic UR2 RNA. Cells transfected with UR2AV alone produced only 35S and
22S RNAs. A ree-specific probe hybridized only with the 24S UR2 RNA. The
RNA patterns of all UR2AV-transfected cells were identical; however, as expected
from the reverse transcriptase assay, no viral RNAs were detected in clone lC-l­
transfected CEF.
Viral specific proteins were also analyzed. CEF transformed by the molecular
clones were labeled with [35S]-methionine, and cell lysates were precipitated with
RSV-infected tumor-bearing rabbit (TBR) or anti-gag sera (Fig. 11). DNA­
transfected and virus-infected cells gave essentially similar patterns with the
same antisera, which precipitated the gag-r08 fusion product, P68. Recognition
of P68 by TBR serum was apparently via the gag peptide in P68. The appear­
ance of P68 as a doublet in virus-infected cells has been observed previously (17),
and apparently reflects the existance of a variant in the UR2 stock. The V8
digestion pattern of the two species are identical (Ellen Garber, unpublished), and
only a single species is seen after a kinase assay. In addition, only a single species
migrating at 68 kd is detected after metabolic labeling or kinase assay of proteins
extracted from CEF transformed by the molecular clone. For assaying the kinase
activity, cold cell lysates prepared from UR2/UR2AV-transfected CEF were
immunoprecipitated with TBR or anti-gag serum and incubated in vitro with
h32p]_ATP. Fig. 12 shows the results of this assay, which indicates that P68
was associated with protein kinase activity. The much lower level of P68 kinase
activity in the transfected cell lanes compared with that in virus-infected cells
was due to the fact that only about 20% of the transfected cells were
transformed at the time of the experiment, as opposed to complete transforma­
tion in the virus-infected culture. The radioactivity in the control TBR lane is
due to phosphorylation of IgG by a contaminating kinase in the antiserum (Ellen
Fig. 11. 35S labeling of proteins from UR2 and UR2AV DNA transfect­
ed cells. Cell lysat es prepared from cR2 and CR2AV transfected CEF that had
been labeled for 5 h with 500 uCi per 6 cm plate of [35jS-methionine were immu-
noprecipitated with TBR or anti-gag serum. The immune complexes were sub­
jected to electrophoresis on an SDS 5-15% polyacrylamide gradient gel. 35S_
labeled proteins from cell lysates of uninfected and L'R2(CR2AV)-infected CEF
were analysed in parallel.
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Fig. 12. Protein kinase assay of UR2 and UR2AV DNA transfected cell
extracts. Cell lysates from CEF transformed by the molecular clones were pre­
cipitated with TBR or anti-gag serum and incubated in vitro with [132p]ATP.
The phosphorylated proteins were analysed on an SDS 8.5% polyacrylamide gel.
Cell lysates prepared from uninfected and UR2(UR2AV)-infected CEF were treat­
ed similarly and used as controls.
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Garber, unpublished). The non-P68 bands seen In the virus-infected culture In
Fig. 12 were most likely due to incomplete washing of the immunocomplex. It
was observed before that IgG could be phosphorylated by P68, in particular when
TBR serum was used in the immunoprecipitation (17).
The above studies show that molecularly cloned UR2 and UR2AV DNA are
biologically active and indistinguishable in effect on CEF from their respective
parental viruses.
Although UR2 DNA could readily induce transformation of CEF when
cotransfected with UR2AV, so far I have not been able to transform a rat cell
line, 3Y1, with UR2 DNA. Under similar conditions, 3Yl cells could be
transformed by either SR-A or FSV DNA (38, 62, L.-H. Wang, unpublished data).
The reason for the failure of UR2 DNA to transform 3Yl rat cells is not clear. It
is possible the promoter sequence in UR2 DNA might not be efficiently recognized
in the rat cells, or that a second oncogene may be required for ros to induce com-
plete transformation of rat cells (31).
Restriction maps of UR2 and UR2A V DNAs.
Restriction maps of UR2 and UR2AV were constructed by two methods. In
the first approach, 32P-end-Iabeled DNA was partially digested with restriction
enzymes and analysed by gel electrophoresis. In the second approach, restriction
enzyme-digested, unlabeled DNA was hybridized with gene-specific probes to
determine the physical order and the genetic content of the DNA fragments. The
results of such mapping for UR2AV and UR2 DNAs are shown in Fig. 13.
The UR2AV DNA containing two LTRs is 8.0 kb and several of its restric­
tions sites are similar to those of Rous-associated virus-2 (RAV-2) (51). The
Kpnl, Sstl, and BamHI sites in RAV-2 are conserved in UR2AV. A HindIIl site in
RAV-2 is also conserved in UR2AV, although UR2AV contains two extra HindIIl
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Fig. 13. Restriction map of cloned UR2AV DNA. UR2AV proviral DNA
was purified from clone 14-1, and restriction enzyme sites were determined. S,
SstI; B, BamHI; E, EcoRI; X, XbaI; K, Kpnl. The genetic structure was deter­
mined by hybridization of UR2AV restriction fragments to probes specific for
various regions of the RSV genome. The UR2 DNA was included here for corn-
parison to show the helper virus-related and TOS sequences.
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sites in the env region. Similarly, UR2AV shares with RAV-2 two EcoRI sites,
yet has an additional EcoRI site in the middle of the UR2AV genome. It
does
not contain an EcoRI site in the LTR, as does RAV-2.
By comparing the restriction maps of UR2AV and UR2 DNAs, the gag-ros
and ros-en» borders may be determined. Construction of a detailed map of UR2
(Fig. 14) allowed a more precise definition of the gene borders than those deter­
mined before (82). UR2 DNA has a single EcoRI site. There is no corresponding
EcoRI site in UR2AV DNA, suggesting that this site is located within the ros­
specific sequence. The gag-ros boundary appears to be located very close to the
Hadl site immediately upstream from the right-hand EcoRI site, because the 460
bp Hadl B fragment hybridized strongly to a UR2 representative probe and
weakly to a UR2AV representative probe and the 5' gag probe (data not shown).
The Pvull B fragment appeared to contain only ros sequence since it hybridized
only to the UR2, but not the UR2AV, cDNA probe. The ros-en» boundary was
mapped between the Pvull site and the second A val site from the left, because
the Aval B fragment hybridized to both the UR2 and UR2AV cDNA probes (data
not shown). Since the A val B fragment could not hybridize with gag, pol, and c
probes, I inferred that the sequence present in this DNA that was hybridizable
with UR2AV cDNA must be the env sequence. The mapping is consistent with
the previous finding that two highly conserved env-specific oligonucleotides, spots
11 and 12a, located at 96 and 594 nucleotides, respectively, upstream from the
termination codon of gp37 of the SR-A genome, were present in the UR2 genomic
RNA (82). Given the estimates of these borders, ros is about 1.2 kb in length.
From the results of the restriction enzyme analysis, I concluded that the 002
genome is 3.4 kb in length, containing in the middle about 1.2 kb of transforming
sequence, ros. UR2 shares with UR2AV 0.8 kb of 5' leader and �gag and 1.4 kb
of 3' � env and c sequences.
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Fig. 14. Restriction map of cloned UR2 DNA. The 3.4 kb UR2 DNA
insert was isolated from pUR2 and restriction sites were determined as described
in Materials and Methods and the Results sections. The numbers in the boxes
indicate the length in bp of the individual restriction fragments. The sizes of res­
triction fragments AvaI E, AvaI F, Bgffi B, NC'tD and HindIII Care 160 bp, 120
bp, 125 bp, 125 bp, 60 bp, and 67 bp, respectively.
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Homology between e-ros and other transforming genes.
Previous comparison of the ros sequence with those of src, Ips, and yes by
liquid hybridization between viral RNAs and cDNAs specific to individual v-onc
sequences detected no significant homology between ros and the rest of the ASV
transforming genes (61). However, it is possible that the homology may be res­
tricted to a small region of ros and thus can not be easily detected by hybridiza­
tion between total viral RNA and the cDNA probe representing the entire
domain of a v-onc gene. To test this possibility, we undertook the approach of
subdividing the ros sequence by digestion with enzymes known to cut within ros
and hybridizing the individual fragments with probes prepared from other v-onc
Di'\As. Probes derived from the 3' regions of src, [ps and yes were used since
these regions were shown to contain the sequences conserved among those
transforming genes (29, 60, 62). The results are shown in F][.:. 15. No significant
hybridization was detected between v-ros and v-yes even under conditions of low
stringency (35% formamide, 5X SSe), although the v-yes probe cross-hybridized
with the 3.1 kb EcoRI fragment of SR-A (from pTTI07) containing the entire v­
src sequence as well as with the 0.75 kb PstI 3'-src specific fragment (from
psrcB). The high degree of amino acid sequence homology within the C-terminal
half of ppBOsrc and pp90Yes has been shown previously (9, 29). Hybridization of
this v-yes probe to UR2 DNA fragments containing gag and env sequences and to
UR2AV DNA is apparent in Fig. 15A. This was due to contamination of the
yes-specific probe with helper virus-related sequences of Y73, since the 1.1 kb 3'
v-yes fragment was slightly contaminated with the 1.4 kb gag-5' yes fragment
and the 1.5 kb fragment containing the env and LTR region of Y73 (29). The
1300 bp NruI·B fragment (Fig. 14) hybridized to this 3' yes probe, apparently due
to the env sequences present in this DNA. Neither of the res-specific fragments
(HincH Band PvuTI B) hybridized with the 3'-yes probe.
Fig. 15. Homology between v-ros and 3' v-onc regions. UR2 DNA insert
was digested with restriction enzymes cleaving within r08 to yield 5'- and 3' ros­
specific fragments. pTTI07 and psre6 sre-containing plasm ids (see text) and the
pBRF04 Ips-containing plasmid DNA were cut with the appropriate enzyme to
free the one insert. The amount of each DNA added per well was adjusted to
yield approximately 50 ng of each one DNA fragment containing the putative re­
gion of homology. The DNAs were fractionated on 1% agarose gels and
transferred to nitrocellulose filters. The probes used in each hybridization were:
(A) 1.1 kb PstI fragment from >..-Y73; (B) 0.9 kb PvuII fragment from pTTI07,
(C) 0.75 kb PvuII - EeoRI from pUR2, (D) 0.4 kb BamHI insert from pBRF04,
and (E) 0.3 kb AvaI - EeoRI fragment of pUR2.
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As shown in Fig. l5B, no hybridization between v-src and v-ros sequences
could be detected, although intense hybridization of the v-src probe to pTTI07
EcoRI and psrc6 Psti was seen. The upper band of the doublet in the psrc6 lane
represented the partially digested, linearized psrc6; the lower band, which hybri­
dized with much less intensity, was the pBR322 vector. The insert src DNA used
as probe might not have been completely purified from the pBR322 vector after
one cycle of gel purification. The EcoRI-PvuII ros-specific probe hybridized to
the expected ros-containing but not to the src-containing DNAs (Fig. l5C).
However, under low as well as under moderate (50% formamide, 3X SSC)
stringency, the 400 bp probe representative of the 3' conserved region of v-Ips
(the BamHI insert from pBRF04, 62) hybridized significantly to v-ros (Fig. 15D).
Aval cleaves UR2 into 6 fragments (Fig. 14), four of which contain portions of
the entire v-ros: the 460 bp A val C fragment covers the gag-ros junction includ­
ing approximately 300 bp of 5' v-ros; the 160 bp Aval E and the 300 bp AvaI D
fragments contain only internal v-ros sequences; and the 550 bp AvaI B fragment
contains approximately 450 bp of 3' ros plus env sequences. Only the 300 bp
A val D fragement hybridized with the v-fp» probe. Conversely, a probe made
from the AvaI D fragment hybridized to the 400 bp 3' v-fps DNA fragment (Fig.
15D and 15E). BgllI cleaves UR2 DNA into the 125 bp B fragment that covers
the 5' portion of the Aval D fragment, and the 3275 bp A fragment containing
the rest of the genome (Fig. 14). The v-fps probe hybridized only to the 3275 bp
BgllI A fragment (Fig. l5D), indicating that the sequences homologous to v-fps
were contained within a 175 bp ros sequence between the BglII and AvaI sites.
However, the possibility that failure to detect the BglII B fragment might be due
to the inefficiency of DNA transfer cannot be excluded.
The location of Ips-related sequence within v-ros is reminiscent of that of v­
abl (52) among the transforming genes coding for tyrosine protein kinases. We
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checked the homology between v-ros and v-abl. Using a probe derived from the
5' 1.2 kb of v-abl DNA (54), no significant hybridization could be detected (data
not shown).
Nucleotide sequence of the UR2 genome.
The sequencing strategy of pUR2 is shown in Fig. 16. Since pUR2 was
derived from a UR2 circular DNA molecule cut with EcoRI, the UR2 genome in
this clone is permuted with respect to the EcoRI site in ros (Fig. 16). However,
the complete UR2 genomic sequence (shown in lower case letters) is presented in
Fig. 17 as colinear to the viral RNA genome which begins at the predicted cap
site (nucleotide 1) and ends at the polyadenylation site (nucleotide 3165). The
gag-ros fusion protein P68 begins with the initiator amino acid methionine of pI9
at nucleotides 380-382. The ros-specific sequence is fused to gag at nucleotide
position 831. The coding sequence of the transforming protein P68 ends with an
ochre stop codon at nucleotides 2036-2038. The v-ros non-coding region contin­
ues down to nucleotide 2103, and the �gp37 envelope sequence resumes after­
wards. The UR2 LTR is 326 bp long.
Previous restriction enzyme analysis of UR2 DNA showed that UR2 shares
with its helper virus, UR2AV, 0.8 kb of 5' and 1.4 kb of 3' sequences (46). Since
I have not sequenced UR2AV, I compared the UR2 sequence with those of PR-C
RSV (57) in the regions of gag and env in order to determine possible sites of
recom bination between UR2AV and cellular ros in the generation of UR2. As can
be seen in Fig. 18, the UR2 sequence diverges from that of PR-C RSV down­
stream from nucleotide 830 in the 5' region of ros and converges after nucleotide
2103 in the 3' ros region. I concluded that the 5' and 3' recombination sites
between UR2AV and e-ros must be at or very close to nucleotides 831 and 2103
in the p19 and gp37 regions, respectively. The total length of ros is 1273
Fig. 16. Rest.r ict.ion enzyme cleavage map and nucleotide sequencing
strategy of the UR2 genome. The transforming sequence, ros, of the permut­
ed lJR2 molecular clone, pUR2, is defined by the heavy line. The arrows indicate
the direction and approximate extent of sequence determined by either the
Maxam-Gilbert (39) or Sanger (55) method. Abbreviations for the restriction en­
zymes are as follows: A, AvaI; B, BamHI; E, EeoRI; H, HindIII; Ha, HaelI; N,
Netl; P, PvuII; S, SstJ.
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Fig. 17. Complete nucleotide sequence of the UR2 genome and deduced
amino acid sequence of P6S and �gp37. The nucleotide sequence from the
predicted cap site (nucleotide 1) to the polyadenylation site (nucleotide 3165) in
UR2 DNA is shown by the lower case letters. Each amino acid is represented by
a capital letter shown under the second nucleotide of the triplet codon. The R,
U5 and U3 regions of the LTR, the primer binding site (PBS), the polypurine
tract (pp tract), the polylA) signal (PA), and the TATA box are indicated by
heavy lines underneath these sequences. The dashed line under amino acid nos. 8
through 36 of the T08 region indicates the hydrophobic region of the T08 polypep­
tide presumed to be important in membrane association. Nucleotide number is
given at the end of each row of sequence, and every ten nucleotides are marked
by a period over the tenth nucleotide. The one letter symbols for the amino
acids are used: A, ala; C, cys; D, asp; E, glu; F, phe; G, gly; H, his; I, ile; K, lys;
L, leu; M, met; N, asn; P, pro; Q, gln; R, arg; S, ser; T, thr; V, val; W, trp; Y,
tyro
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Fig. 18. Junctions or ros and UR2AV-derived sequences. The numbers
refer to the nucleotide positions of UR2 sequence shown in Fig. 17 and to the
published PR-C RSV sequence (57).
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nucleotides.
Extensive homology was found between the UR2 sequences outside ros and
the corresponding sequences of other avian viruses. Within the 5' 380 bp noncod­
ing sequence of VR2, there are 22, 30 and 19 scattered single base changes rela­
tive to RAV-2 (7), Y73 (29), and PR-C (57), respectively. These changes include
one deletion at nucleotide 371. This change (A in UR2 replaces TG in PR-C)
occurs immediately upstream from the initiation site for translation. It has been
suggested (7) that this upstream region is important for efficient mRNA transla­
tion; we do not know whether this change in any way affects the translation of
VR2 genomic RNA. Sequences within the binding site for the tRNA primer (PBS)
are completely identical to other avian viruses.
The pIg amino acid sequence of VR2 differs from that of PR-C and Y73 by
three and two amino acids, respectively. It is not clear whether these amino acid
changes affect any of the pI9 antigenic determinants; however, P68 could still be
efficiently precipitated by the anti-gag serum apparently by the remaining p19
peptide (see Fig. 21). The gp37 sequence of UR2 is well conserved relative to
PR-C, Y73 and RAV-2 except for the carboxy-terminal region. The termination
codons of gp37 in VR2 (at nucleotides 2627-2629), Y73 and RAV-2 occur 10 bp
further downstream than that in PR-C, and there is considerable divergence in
this region, especially in the stretch spanning the 13 carboxy-terminal amino
acids of gp37 in UR2.
In the V3 region, 18 to 31 base changes were found when compared with
other avian viruses including RAV-2, Y73, PR-C RSV and SR-A RSV (67). 12 of
these changes are in positions unique to UR2, and 8 of these occur in the 3' third
of V3. In addition, there are stretches of deletions and insertions. In particular,
a stretch of 17 bp in the middle of V3 (nucleotides 3023 to 3040 in VR2) is
marked by variable deletions in Y73, PR-RSV and SR-RSV, but not in RAV-2
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and UR2. These changes in UR2 apparently have no pronounced effect on the
efficiency of transcription since UR2 RNA is produced in comparable amounts in
UR2-infected cells relative to the amounts of viral RNAs produced in other ASV
transformed cells (46, 82, unpublished data). The universal signal sequences for
transcription and processing of mRNAs are conserved in all viruses. Sequences in
the inverted repeat regions found at both ends of the LTR, and in the polypurine
tract, are also conserved in UR2. In addition, a region corresponding to the
sequence suggested to be involved in RNA packaging is also present in UR2 (64).
An additional HindIII site 67 bp upstream from the HindIIT site 3' to ros
detected previously by restriction enzyme mapping was discovered after sequenc­
ing the entire 3' region of the UR2 genome (Fig. 17).
Structural domains and reading frames in the UR2 genome.
The location of open reading frames in the region spanning nucleotides 380-
3000 of UR2 is shown in Fig. 19. A long open reading frame in frame 2, begin­
ning with an AUG codon at nucleotide 380 and ending in an ochre stop codon at
nucleotide 2036, encodes the UR2 transforming protein P68. The other open
frame in frame 2 represents the Agp37 sequence. The next largest sequence with
an open reading frame is the 111 amino acid stretch in frame 1; all other open
frames are less than 40 amino acids in length. All the deduced amino acid
sequences of these reading frames except Agp37 begin with an initiator
methionine. It is unlikely that those open reading frames other than the one cod­
ing for P68 are translated because subgenomic mRNAs have not been detected in
UR2-transformed cells (82).
The size of the ros coding region is 1205 bases. A non-coding sequence of 65
bp follows the ochre stop codon of ros and contains four termination codons ,
three of which are immediately adjacent to each other.
Fig. 19. Location of sequences with open reading frames within the
UR2 genome. Considering the predicted cap site as nucleotide 1 of the se­
quence presented in Fig. 17, the genome was translated in all three frames. Only
the region spanning nucleotides 380-3000 is shown here.
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As deduced from the DNA sequence, P68 contains 552 amino acids, of which
150 are encoded by gag and 402 are encoded by r08. The transforming protein
has an apparent' molecular weight of 68 kd as estimated from SDS­
polyacrylamide gel electrophoresis (17), but the predicted molecular weight of the
deduced amino acid sequence is 61,113 daltons. It is unlikely that this
discrepancy is due to glycosylation of the protein, because in vitro translation of
the genomic 24S UR2 RNA yielded a protein product of 68 kd (17). Unusual
amino acid composition such as a high percentage of cysteine or proline could
cause extensive folding and change the relative mobility of the protein in SDS­
polyacrylamide gels (20, 78). The amino acid composition of P68gag-ros shows
that proline comprises only 5.2% and cysteine 2.35% of the protein, so this prob­
ably does not account for the 6.8 kd higher apparent molecular weight. It is pos­
sible that phosphorylation of specific amino acid residues in vivo may alter the
migration of the protein.
The hydrophilicity profile of the r08 domain of the fused protein P68gag-ros
(Fig. 20) revealed one amino- and one carboxy-terminal hydrophobic regions
(shaded area in Fig. 20). The amino-terminal hydrophobic region is 29 amino
acids long (underlined in Fig. 17) and is characterized by a stretch of 13 consecu­
tive hydrophobic amino acids, and is flanked by an acidic residue (aspartic acid)
immediately upstream and a basic residue (arginine) two amino acis downstream
of this sequence. The carboxy-terminal hydrophobic region (from amino acids
448 to 456, Fig. 21) contains nine hydrophobic amino acids flanked by an aspartic
acid and a glutamic acid at N- and C-termini, respectively. With the exceptions
of the r08 and abl (54) proteins, this hydrophobic region is interrupted by serine
in all other tyrosine kinase oncogene products (Fig. 21). P68 in UR2-transformed
CEF remained associated with the plasma membrane during cellular fractionation
even under conditions of high salt (300 mM) (E. Garber et. aI., personal
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Fig. 20. Hydrophilicity analysis of the deduced amino acid sequence of
r08. Positive values on the Y axis denote hydrophilic stretches of amino acids,
and negative values denote hydrophobicity. The two cross-hatched areas indicate
the extensively hydrophobic regions of r08.
- 50-
communication). The amino-terminal hydrophobic region is long enough to span
the membrane, and we speculate that this region may be responsible for the asso­
ciation of P68 with the plasma membrane.
Comparison of P6#ag-ros with other protein kineses.
The region of the deduced amino acid sequence of P68 was compared to the
analogous domains of the proteins encoded by the viral oncogenes src (11, 12,
69), yes (29), [ps (60), Jms (23), erb B (87), Jgr (45) and abl (54) as well as the
catalytic subunit of the cyclic AMP-dependent bovine protein kinase (5, 63) (Fig.
21). Certain highly conserved regions are immediately apparent. The lysine resi­
due which is the proposed ATP-binding site of BPK is conserved in ros (amino
acid no. 283), and so is the characteristic sequence Leu-Gly-X-Gly-X-Phe-Gly-X­
Val 15 to 20 residues upstream from the binding site (5). This region is highly
conserved in all the kinases under comparison and is likely to be an important
structural domain. Two other highly conserved regions include a 26 residue
stretch 28 amino acids upstream from the putative phosphotyrosine acceptor site
(amino acid no. 419, marked with an asterisk), and the 28 amino acid stretch 6
amino acids downstream from this site (found in row. 5-7 in Fig. 21). Among the
kinase related oncogenes, Jgr and raJ (not shown in Fig. 21) lack demonstrable
kinase activity (37, 45) although they share regions of conserved amino acid
sequences. It is interesting to note that the circled amino acids of ros, which
denote amino acids different from the rest of the tyrosine protein kinases, occur
at the N-terminal regions of both of the two highly conserved sequences. Further­
more, ros contains a unique 6 amino acid insertion (amino acid no. 391-396)
within the highly conserved region, in addition to two other insertions at posi­
tions 344 to 346 and 352 to 353.
I have aligned the tyrosine residue at amino acid no. 419 of ros with the
Fig. 21. Comparison of the amino acid sequences within the conserved
region of protein k inases encoded by ros and other oncogenes and the
catalytic subunit of the bovine protein kinase gene. The 3' no. 246
through 513 amino acids of P68gag-ros have been aligned to show homology with
the other protein kinases. They are: abl (Abelson murine leukemia virus, 54); Ips
(Fujinami sarcoma virus, 60); src (SR-A Rous sarcoma virus, 11, 12, 69); yes (Y73
sarcoma virus, 29); erbB (avian erythroblastosis virus AEV-H, 87); Igr (Gardner­
Rasheed feline sarcoma virus, 45); [ms (McDonough strain of feline sarcoma virus,
23); and BPK (catalytic subunit of the cyclic AMP-dependent protein kinase from
bovine cardiac muscle, 63). Amino acid number is given preceding each row of se­
quence. The putative phosphotyrosine acceptor site of v-ros (amino acid no. 419)
is marked with an asterisk. Regions of conserved amino acids among the proteins
are boxed. Amino acids of ros at positions 365, 370 and 426 are circled to show
the unique differences from the rest of the tyrosine protein kinases.
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known tyrosine phosphoacceptors of the other protein kinases. The region sur­
rounding the tyrosine phosphoacceptor site appears to be somewhat conserved,
although its essentiality is not clear, in several tyrosine protein kinases (Y73 P90,
PR-CII PI05, p60src and ST-FeSV P85) in that the phosphotyrosine is located
seven residues to the carboxy-terminal side of a basic amino acid (arginine or
lysine) and either four residues to the carboxy-terminal side of or adjacent to a
glutamic acid residue (50). However, the likely phosphoacceptor tyrosine residue
at position 419 of roe is four residues and two residues to the carboxy-terminal
side of a lysine and an aspartic acid, respectively. No tyrosine-containing pep­
tides in the deduced amino acid sequence of P68 concur with the above proposed
consensus sequence. This implies that there is some degree of flexibility with
respect to primary amino acid sequence at the phosphotyrosine acceptor site.
Although P68gag-ros is phosphorylated on serine residues in vivo (17), I cannot
speculate which residues in particular are possible phosphorylation sites.
The N-terminal 95 amino acids of r08 upstream from the region compared in
Fig. 21 vary greatly from the corresponding domains of other protein kinases, and
are characterized by a long stretch of hydrophobic sequence mentioned above.
Previous hybridization of roe DNA to Ips, src, yes and abl DNAs detected
significant homology only to Ips (46). However, there is greater amino acid
homology among r08, abl and src than between r08 and Ips. This is due to
degeneracy of the triplet code. The longest stretch of nucleotide homology
between r08 and Ips has been localized to the region upstream of the tyrosine
phosphoacceptor site, where the sequences are identical for 40 nucleotides, with
the exception of a single base change at the 18th position within this sequence.
It is evident from the deduced amino acid sequence that P68 is a member of
the tyrosine protein kinase family. Aside from the unique amino acid changes
and insertions within the conserved domain of the protein kinases compared here,
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P68 contains two distinctive highly hydrophobic regions, III particular in the 5'
region of ros. Any combination of these changes could be responsible for modu­
lating the P68 activity and for the specific interactions between P68 and its cellu­
lar targets that lead to the unique elongated transformed CEF morphology.
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Section IV. Results
[e-ros]
Heteroduplez and restriction mapping of e-ros.
A recombinant DNA clone containing sequences homologous to v-ros was iso­
lated from a library composed of partially-digested chicken genomic DNA cloned
into Charon 4A with EcoRI linkers by Masabumi Shibuya in our laboratory. v­
ros is permuted at the EcoRI site in pUR2, and an uninterrupted ros sequence
was desired for heteroduplex mapping with the lambda e-ros clone. Therefore,
the EcoRI insert from pUR2 was freed from the vector, ligated, cut with HindIll
and subcloned into the HindIII site of pBR322. Heteroduplex mapping of the
lambda e-ros DNA with the HindIII insert DNA, done in collaboration with
Ming-Ta Hsu at this University, showed that the v-ros homologous sequences in
e-ros are distributed in eight exons, ranging in size from .11 to .19 kb, and are
interrupted by seven introns, ranging in size from .3 to 3."8 kb (Fig. 22). The
polarity of e-ros was oriented by the unequal length of the the 5' 1.3 kb and 3'
0.9 kb UR2 sequences not in the complex. The size of the exons and introns were
calculated as the average values from the measurement of 30 heteroduplexed
molecules (data not shown).
When CEF DNA was analysed by digestion with various restriction enzymes
and subsequent hybridization of the restriction fragments with probes 150-250 bp
in length derived from various regions of v-ros, the cellular ros gene appeared to
be distributed over 11.7 kb, which was in good agreement with the results from
electron microscopy. Analysis of the lambda recombinant clone, using the same
restriction enzymes and hybridization probes as for CEF DNA, agreed fairly well
with the results from heteroduplex mapping and CEF analysis. The presence of
Fig. 22. Heteroduplex mapping of pUR2 with Xc-ros DNA. The EeoRI
insert of pUR2 was freed from the vector, ligated, digested with HindIII, recloned
into the HindIII site of pBR322 and cut with SstI to provide a non-permuted v­
ros gene. Heteroduplex mapping was done in collaboration with Ming-Ta Hsu at
this Institute.
UR251
3'
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partially-digested DNA after restriction enzyme digestions of CEF DNAs
obscured a complete analysis of the e-ros DNA, but analysis of the lambda e-ros
clone by 32p end-labeling and partial restriction enzyme digestion, and by South­
ern blotting analysis using the same v-ros DNA probes mentioned above, enabled
me to construct a restriction map to orient the e-ros clone relative to v-ros and
to determine the approximate introri/exon boundaries (Fig. 23).
Sequencing of cellular ros.
The e-ros insert from the lambda clone contains two EcoRI sites (Fig. 23),
and can be digested with EcoRI into 5' 5.2 kb, internal 9.7 kb, and 3' 1.7 kb
fragments. These EcoRI DNA fragments were subcloned into pBR322. Each
fragment prepared from the pBR322 clones was further divided into several res­
triction fragments and subcloned into an MI3 phage vector for Sanger dideoxy
sequencing (Fig. 23). I am currently sequencing the region I believe to contain
the 65 bp exon 4.
Fig. 24 details the differences found between viral and cellular ros. In exon
one, there is a 9 bp insertion in v-ros which adds 3 hydrophobic amino acid resi­
dues (specifically serine, leucine and threonine) to the carboxy end of the amino­
terminal hydrophobic region of viral ros. Therefore, v-ros contains a stretch of
29 and e-ros a stretch of 26 hydrophobic residues. The sequence inserted in v­
roe, GCTTGACTA, is a direct repeat of the immediately preceding 9 bases. The
26 amino acid hydrophobic stretch in c- ros is still of sufficient length to span the
plasma membrane.
Additionally, a single base pair change has been noted in exon nine: C in c­
ros has been changed to an A in v-ros; however, the amino acid, arginine, is con­
served.
The 3' ends of viral and cellular ros diverge before the termination codons
Fig. 23. Restriction enzyme cleavage map and nucleotide sequencing
strategy of Xc-ros. Exons are denoted by the black boxes. The arrows indicate
the direction and extent of sequencing determined by the Sanger method (55).
Abbreviations for the restriction enzymes are as follows: A, Aecl; B, BamHI; C,
ClaI; H, HindIII; Ha, HaeIII; Hi, Hinjl; N, Neol; P, PstI; Pv, PvuII; R, EeoRI; RV,
EeoRV; S, SstI; St, Stul.
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Fig. 24. Sequence of v-ros homologous sequences in e-ros. Exon boun­
daries are denoted below the sequence in addition to any changes occurring in v­
ros. Ellipses under the exon 4 sequence indicate it has not yet been sequenced.
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ATACTGTGAC CTCTCCAGAT ATCACTGCTA TTGTTGCTGT GATTGGAGCA GTTGTACTGG
L exon 1
.70 80 90 100 110 120
GCTTGACTAT AATCATACTG TTTGGTTTT:t:ATGGCACCA AAGATGGAAA TCCAGAAAAC»<;
GCTTGACTA
exon 1 exon 2
130 140 150 160 170 180
CAGCCTCAAC TGGGCAGATT GTGCTTGTCA AGGAAGATAA AGAATTAGCT CAACTTAGGG
190 200 210 220 230 240
GAATGGCTGA GACAGTGGGA TTAGCCAATG CTTGTTATGC TGTCAGCACT CTTCCTTCTC
J.
exon 2 exon 3
250 260 270 280 290 300
AAGCAGAGAT TGAGTCATTG CCAGCTTTTC CTCGGGACAA ACTGAACTTA CACAAGTTGT
310 320 330 340 350 360
TAGGAAGTGG AGCATTTGGA GAGGTGTATG AAGGGACTGC ATTAGATATC CTGGCAGATG
370 380 390 400 410 420
GAAGTGGAGA ATCCAGAGTA GCAGTCAAGA CTTTGAAGAG AGGTGCAACA GACCAAGAGA
.1.........................................
exon3 exon 4
430 440 450 460 470 480
AGAGTGAATT CTTGAAGGAG GCACACTTAA TGAGTAAATT TGATCATCCC CACATTCTGA
...........................................J.
exon 4 exon 5
490 500 510 520 530 540
AGCTACTTGG AGTGTGTCTG TTAAATGAAC CTCAGTACCT TATACTGGAG CTGATGGAAG
550 560 570 580 590 600
GAGGAGATCT GCTTAGCTAT TTACGAGGAG CCAGAAAGCA AAAGTTCCAG AGTCCCTTAC
exon 5
.L
exon 6
610 620 630 640 650 660
TGACATl'GAC TGATCTCTTG GATATATGCT TGGATATTTG CAAAGGTTGT GTCTATTTAG
670 680 690 700 710 720
AGAAAATGCG TTTCATACAC AGGGACCTGG CTGCTCGCAA CTGCCTTGTG TCTGAGAAGC
exon 6 J. exon 7
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AATATGGGAG CTGCTCCCGA GTGGTAAAGA TTGGTGATTT TGGACTTGCC AGAGATATCT
790 800 810 820 830 840
ATAAAAATGA TTACTACAGG AAAAGAGGA::; AAGGCCTACT CCCTGTCAGA TGGATGGCTC
850 860 870 B80 B90 900
CTGAAAGCCT CATTGATGGC GTCTTTACAA ATCACTCTGA TGTTTGGGCT TTTGGAGTCT
exon 7 J_ exon 8
910 920 930 940 950 950
TAGTGTGGGA AACATTAACT TTGGGTCAAC AGCCATATCC GGGTCTCTCC AATATAGAAG
970 980 990 1000 1010 1020
TTTTACACCA TGTACGATCA GGAGGAAGGC TGGAATCTCC GAATAACTGT CCTGATGACA
1030 1040 1050 1060 1070 1080
TACGTGATTT AATGACACGA TGCTGGGCCC AAGATCCTCA CAACAGACCT ACTTTCTTTT
L
exon 9 0
1090 1100 1110 1120 1130 1140
ATATTCAGCA CAAACTGCAA GAGATAAGGC ACTCTCCACT GTGCTTCAGC TACTTCCTTG
1150 1160 1170 1180 1190 1200
GAGACAAAGA GTCAGTGGCT GGTTCATCAA CCAAGCTTTT GAGGGTAAGC CTGGGCAGTG
Ldivergence .....
1210 1220 1230 1240 1250 1260
CTGTCCCCAC AGCTTTTGCC CAAACCTGCA ACAGTGTAAA CGTAGAATCA CAAAATGGCT
1270 1280
TAGGTTGGAA GGGACCTTAA
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of both genes (Fig. 25). In UR2, as described above, the stop codon of viral ros is
followed by a noncoding region of 65 bp that includes four more in frame termi­
nation codons. However, e-ros and v-ros abruptly diverge 36 bp or 12 codons
upstream of the v-ros stop codon. e-ros continues for 102 bp or 34 amino acids
before reaching a termination codon (Fig. 25A). However, there is a splice donor
sequence, AGG-GTAAGC (dashed box in Fig. 25A) 21 bp (or 7 amino acids) after
the divergence, and a splice acceptor, CTTCAATTTCCCCATTAG-C, approxi­
mately 525 nucleotides from the GT dinucleotide of the donor site. If these sites
are used for splicing, then c-ros would continue for an additional 9 amino acids
before termination (Fig. 25B). There are two additional possible splice donor
sites just upstream of the possible splice acceptor; however, no other possible
splice acceptor consensus sequences were found. The 3' 1.4 kb downstream of the
divergence in c-ros does not contain an AAUAAA sequence; although the variant
poly(A) signal AGTAAA, found in MTV and BaEV (71, 74), is found in a single
copy, the consensus sequence YGTGTTYY (40) was not found downstream. No
other sequences corresponding to the two other known variant poly(A) signals,
AVUAAA and AAUAUA (1, 35, 73), were found. The 3' 500 bp of the c-ros
clone is marked by stretches of As and Ts.
There is no homology between the 3' divergent region of v-ros and the 1.4 kb
3' noncoding sequences in the C-TOS clone, nor is there any apparent homology
between the v-ros divergent region and any viral or chicken genes sequenced to
date. Hybridization of a probe containing only the v-ros divergent sequence to
CEF DNA is under progress to determine whether this region might be part of e­
ros sequences found further downstream, or whether it might have arisen from
another locus in the chicken genome.
These results suggest the c-ros protein differs from v-ros for the 12 carboxy­
terminal amino acids of V-T08, although it is unclear how much larger the
- 60-
A
r
di vergence
5 V A P L R! Q T A F F Q
P Lr:-:-;:l
teo gtg get CCA CTG CGG ATT CAG ACA GCA TTC TTT CAA CCA CTC�Y-ros
(-ros t�o g�g 9�t��T TtA TtA A�C A�G ch T�Gl������{�����lc�G G�C
5 A V PTA F A Q TeN 5
V N
AGT GCT GTe ccc ACA GCT TTT GCC CAA ACC TGC AAC AGT GTA
AAC
V Q 5 Q N G L G \01 K G
P r:-:-:l
GTA GAA TCA CAA AAT GGC TTA GGT TGG AAG GGA CCT�
B
Y-ros
cca
L
ctc taa
A
tL
R 1 Q T A.
--gct eca ctg cgg att cag aca gca ttc ttt caa
divergence
Q
[-res
.l<t-
SST K
--get g£: tea tea ace aag c·+
divergence
L
ttg
R
(525 bp) L
AGG" GT A
,,�G:,,4�
(t
)4::,:�,),��'���'�'
C ta
, "
, "
V A R
agg gtg gea ctt egg
H
eae
L
tta ctt tag
Fig. 25. Comparison or the 3' ends or viral and cellular r08. A. Deduced
amino acid sequence of 3' e-ros if ochre stop codon (boxed) is used. Potential
splice donor is shown in dashed box. B. Deduced amino acid sequence of 3' e-ros
if splice donor (upper case letters) is used, showing potential splicing to the
acceptor signal (upper case letters) approximately 525 bp downstream.
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carboxy-terminus of e-ros may be. Several oncogenes, including src, myc, myb,
and [os, differ from their viral counterparts in the C-terminal region.
In UR2, the 5' end of v-ros is fused to the 3' coding region for pIg, and P68
uses the UR2 promoter and the initiator methionine of gag. The beginning of v­
ros corresponds to a consensus splice acceptor sequence in e-ros (Fig. 26). 340 bp
upstream of this splice acceptor has been sequenced, and there are stop codons
both in and out of frame relative to v-ros. In addition, there do not appear to be
any promoter sequences, indicating there exists an additional upstream exon (or
exons) in c- ros. Preliminary sequencing of the corresponding region of the
UR2AV molecular clone 14-1 reveals a splice donor signal (Fig. 26). This suggests
that the viral ros and �gag junction in UR2 was formed by splicing.
Fig. 27 shows the splice acceptor, the size of the exon, and the splice donor
for each known exon of e-ros. The exons range in size from 65 to 204 bp. The
sizes of the exons and introns even within the conserved kinase domain do not
appear to be conserved when compared with those of c-fps and c-src (27, 70).
Expression of cellular ros.
To study the expression of c-ros, I extracted polY(A)-containing RNA from
chicken and quail embryo fibroblasts as well as from HeLa, 3Y1, 3T3, and QT6
cell lines (human, rat, mouse and quail origin, respectively). The RNA was dena­
tured by treatment with glyoxal, and 20 ug of each RNA species was analysed by
Northern blotting using using a ros-specific probe (Pvull B fragment, Fig. 14)
under conditions of low stringency (35% formamide, 5X SSC). No res-specific
transcripts were detected; however, hybridization with a src-specific probe
showed strongly hybridizing bands corresponding to expected c-src transcripts
from CEF, QEF, and QT6, and fainter bands from 3Y1 and 3T3 cells not
expressed, or expressed at an
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Fig. 26. Comparison of the 5' regions of the junctions of viral and cellu-
lar rose The consensus splice signals are shown, as well as the corresponding
region from UR2Av.
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Fig. 27. Exon size, splice acceptor and splice donor signals in c- rose
EXON
CONSENSUS
1
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3
4
5
5
7
8
9
ACCEPTOR BP ROS (SIZE IN BP)
1 - 90 (90)
91 - 225 (136)
227 - 389 (163)
390 - 454 (55)
(�)5ACCATAAAATTCAG-G 683 - 886 (204)
<t>4TTAG-G 887 - 1021 (135)
102.2 - (139+)
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CAG-GTAAGT
A G
TTG-GTATGT
CAG-GTATGT
AAG-GTAATC
AAG-GTAGGA
CAG-GTACAG
TTG-GTGAGC
CAT-GTAAGT
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extremely low level (less than one copy per cell) in those cells. However, the pos­
sibility that the e-ros transcript is very unstable cannot be excluded since I have
been looking at steady-state RNA. Nevertheless, previous analysis using liquid
hybridization and unselected total cellular RNA did not detect e-ros transcripts
in most tissues examined from two week old chickens (61).
I also examined several tissues from chicken at different embryonic and adult
developmental stages to determine the pattern of cellular ros expression in
chicken. Twice poly(A)-selected RNA was isolated from brain, eye, muscle, gut,
heart, liver, and lung, and from extraembryonal membranes, from 12, 14, 16, 18,
and 20 day old chick embryos (lung tissue was not isolated from 12, 14, or 16 day
embryos), and from 2 day and 7 day old chicks. In addition, kidney mRNA was
isolated from 4 and 7 day old chicks. The RNAs were hybridized with a src­
specific probe (Fig. 28) or a ros-specific probe (Fig. 28). Fig. 28 depicts only the
12 and 14 day embryo and 2 day and 7 day chick timepoints. Hybridization with
the src-specific probe as a positive control showed transcripts of the expected size
in the appropriate tissues: a 4 kb transcript was seen in all tissues where src is
expressed except for muscle, where the multiple forms of smaller RNAs were seen
as previously observed by Iijima and Wang (unpublished data). These src tran­
scripts can be detected after a 17-20 hour exposure of the blot with an intensify­
ing screen. However, even after a 96 hour exposure, no obvious evidence of ros
expression is seen after hybridization of the Northern filters to the res-specific
probe.
A faint signal was detected in kidney tissue at the 7 day timepoint; even
fainter was a possible band in adult muscle tissue. To verify these results,
poly(A)-selected mRNA was isolated from kidney at 20 day embryo and 3, 7, 10,
and 14 day old chicks (Fig. 29). A 3.1 kb transcript from muscle was detectable
in 7 day old chick and gave its strongest signal at 10 days. This transcript was
Fig. 28. Expression of C-TOS. Twice poly(A)-selected mR�A from the tissue
indicated was denatured with glyoxal, electrophoresed through a 1 % agarose gel,
blotted onto nitrocellulose and hybridized with a src-specific or a res-specific
probe.
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Fig. 29. Expression of e-ros. Twice poly(A)-selected mRNA from kidney and
muscle tissues from chicken was denatured with glyoxal and subjected to electro­
phoresis througha 1 % agarose gel and transferred to nitrocellulose. Hybridization
was with a ros-specific probe.
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not detectable in 20 day embryo or 14 day chick, suggesting the C-TOB gene IS
activated only briefly in this tissue. Muscle mRNA from chickens one month or
older appears negative for TOB expression (data not shown). A similar sized tran­
script can be found in kidney from 20 day embryo to 14 day old chicks, although
this signal was not seen in mRNA isolated from chickens one month and older.
The TOB mRNA in kidney appears to be more degraged than the correspond­
ing BTC mRNA, and I cannot exclude the possibility that the cellular TOB message
is preferentially degraded in this tissue. It is possible that lack of detectable
transcripts in kidney with the ros-specific probe may not reflect a very low level
of transcription but rather a greater instability of the message. These results are
preliminary; however, it is apparent that in the tissues screened, the cellular TaB
locus is under very stringent control, most likely due to repression of transcrip­
tion.
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Section V. Discussion
Avian sarcoma virus UR2 is a replication-defective virus that can induce sar­
comas in vivo and transforms chicken embryo fibroblasts in culture to a charac­
teristic, extremely elongated morphology (4). The genome of UR2 contains a 1.2
kb transformation-specific sequence, v-ros, which has a homologous counterpart,
c-ros, in normal chicken cellular DNA (61). UR2 was presumably generated by
recom bination between UR2AV and e-ros at the expense of certain replicative
sequences in UR2AV. As a result, ros was fused to the 5' region of the UR2AV
sequence which codes for part of the viral structural protein pIg (82). The fused
pIg and ros sequences in UR2 code for a polyprotein of 68 kd, called P68, which
was found to be associated with a tyrosine-specific protein kinase activity (17).
P68 has similar biochemical properties to the protein kinases encoded by several
other oncogenic viruses, and this functional conservation implies that ros must be
closely related to the tyrosine protein kinase-encoding oncogene family. However,
P68 differs from the kinases encoded by FSV, ASV Y73 and RSV in many enzy­
matic properties. To elucidate the basis of the functional conservation as well as
the differences between ros and other oncogenes, I sequenced the entire genome of
UR2 and compared the predicted amino acid sequence of P68 with other
mem bers of the tyrosine protein kinase family.
The results show that ros is 1273 nucleotides in length, including a 65 bp 3'
noncoding stretch. The deduced amino acid sequence for the UR2 transforming
protein P68 gives a molecular weight of 61,113 daltons and shows that it is
closely related to the oncogene family coding for tyrosine protein kinases. How­
ever, P68 contains two distinctive hydrophobic regions that are absent in most of
the other tyrosine kinases and it has unique amino acid changes and insertions
within the conserved domain of the kinases. Fig. 30 summarizes the structural
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Fig. 30. Structural domains of P68gag-ros. A portion of the pIg region of
gag is fused to r08 at the amino terminus. The amino- and carboxy-terminal
hydrophobic regions (H) are marked with small boxes. The possible phosphotyro­
sine acceptor site (Y) is indicated within the conserved kinase domain of ros.
- 70-
domains of P6Sgag-ros.
The cellular homologues of the retroviral transforming genes, called cellular
oncogenes or proto-oncogenes, have been highly conserved during the course of
evolution. Several of the cellular oncogenes are expressed in a tissue-specific
manner, and in many cases the sizes of these transcripts have been maintained
across widely divergent species. It is currently believed these genes play an
important role in cellular growth and/or differentiation, and appear to have an
oncogenic potential that can be manifested after transduction by a retrovirus.
The process of conversion from a normal proto-oncogene to a transforming
oncogene can involve either mutation of the gene or deregulation of the gene, or
both. I have determined the sequence of cellular ros and compared it to that of
viral ros to determine the changes between them that may be responsible for
t heir differential oncogenicity. In addition, I have analysed the expression of the
cellular gene in both em bryonic and adult chickens in an attempt to understand
the normal function of cellular ros.
Conservation of the viral and cellular ros genes.
Viral oncogenes and their corresponding cellular homologues are closely
related. In fact, excluding the 3' divergence, the 1.2 kb v-ros sequence is remark­
ably well conserved when compared with the corresponding region of e-ros. The
v-ros sequences are distributed in nine exons of e-ros over a range of 12 kb of
DNA (Fig. 31). e-ros and v-ros differ only by a 9 bp duplication, a single base
change not resulting in an amino acid change, and the divergence of their 3' ends
(see Fig. 24). The viral reverse transcriptase has been shown to have a high fre­
quency of mismatch (21) and it has been speculated that the scattered nucleotide
changes between viral and cellular oncogenes are a consequence of faulty reverse
transcription during replication (30). UR2 was molecularly cloned from virus
Fig. 31. Derivation of e-ros exon sequences from v-ros. Numbers above
and below the exons (solid black boxes) denote the corresponding nucleotide in
v-ros.
�-vQ. -..0 -� � -{
\
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that had been through a limited number of passages since its isolation
from the
original tumor. The striking degree of conservation between viral and
cellular ros
may result from limited opportunity for the reverse transcriptase to induce
muta­
tions in the viral gene. A similar degree of conservation between viral and
cellu­
lar oncogenes for which sequences are known has been observed in ASV
PR-CII
where v-fps differs from c-fps by only 4 out of 1700 nucleotides; there are no
amino acid changes (27).
Possible mechanism of transduction of e-ros.
Comparison of the nucleotide sequences of viral and cellular ros suggests the
viral ros and �gag junction in UR2 was formed by splicing (Fig. 32). This is
consistent with insertion of the provirus upstream from the region of e-ros
corresponding to the beginning of v-ros, followed by transcription of the hybrid
DNA and splicing of the transcribed RNA to join �gag to the ros sequence.
Since the beginning of v- ros corresponds to an excellent splice acceptor site in c­
ros, it is more logical to assume the �gag-ros junction has been formed by splic­
ing. However, the possibility exists that the junction was formed by fortuitous
recombination at that position between the virus and C-TOS either at the DNA
level or through an RNA intermediate. Although the UR2AV sequence at the
junction corresponds to a potential splice donor site, this site could be generated
by joining the viral sequence to C-TOS through recombination at the DNA level.
C-TOS and v-ros abruptly diverge 36 bp upstream of the v-ros termination
codon. The open reading frame of e-ros continues after this divergence and may
terminate 34 amino acids downstream, or, more likely,the reading frame is spliced
to further 3' coding sequences using an excellent splice-donor consensus site 27
amino acids downstream of the divergence. The v-ros sequence 5' to the diver­
gence was not found in the 3' C-TOS sequences in the lambda clone or in helper
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UR2AV (-ROS
------_.
flgog
( 1 ) (2 )U3 RU5
11----------
Fig. 32. Mechanism for the generation of the 5' v-ros junction with
UR2AV. e-ros exons are denoted as open boxes. The splice is indicated by the
"v" joining UR2AV and c-ros.
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virus-related sequences. It may represent further downstream sequences
In e-ros
that were joined to the upstream r08 sequence via an abnormal splicing of
the
virus-c-ros hybrid R�A, or via a recombinational event at the DNA level that
deleted the e-ros sequence in between. This sequence may also represent another
locus fused to V-TOS by a recombinational event subsequent to the transduction of
e-ros. Several viral oncogenes and their cellular counterparts are discontinuous at
their 3' ends. The carboxy-termini of viral and cellular 108 differ due to a 104 bp
deletion in the 3' v-fos sequence (77). The 3' end of v-myb is contained within c­
myb, which continues in frame a short distance before termination, or which, like
C-TOS. may use a splice-donor signal that lies just upstream of the stop codon to
extend the coding sequence (30). The carboxy-terminal 12 amino acids of viral
src are derived from chicken genomic sequences found 1 kb downstream of the c­
src termination codon (49). The interposing sequence in c-ere contains a poor
splice donor consensus, and this sequence may be fused to the 3' end of viral 8TC
by an infrequent splicing event, a DNA:D�A recombination (70), or an
R�A:n!,\A recombination during the process of reverse transcription (49). This
sit uation is analagous to that of c-ros, although the origin of the 3' v-ros diver­
gent sequence is not yet clear.
The exact mechanism of transduction of an oncogene by a retrovirus remains
to be further explored, but the accumulating evidence, including the transduction
of c-ros, suggests that it involves nonhomologous recombination between the
virus and the cellular gene, occurring in one or multiple steps at the DNA level.
followed by splicing of the viral-c-onc RNA transcript. The final junctions may
not reflect the original site of recombination. Formation of the 3' viral-c-ros
junct.ion would involve a second recom binat ion between UR2AV and the viral-c­
ros hybrid RNA at the step of reverse transcription.
Although capture of c-ros by UR2AV has resulted in few changes �ithin the
- 75 -
transduced region of the cellular gene, it is possible that truncation
of the 5'
sequences and/or alteration of the 3' end may have activated
the transforming
potential of e-ros. Additionally, fusion of �p19 to e-ros could affect the
confor­
mation of the resulting viral protein. Prywes et. al. (53) have shown that the pI5
region of gag in Abelson m urine leukemia virus is required to stabilize the
transforming protein in lymphoid cells. However, fusion to gag sequences is
dispensable for transformation; although the myc transforming protein of MC29
is a gag-fusion product, myc is independently expressed in MH2. In addition,
� gag is not necessary for transformation by v-fps (18). It is entirely possible,
however, that transformation by v-ros is a consequence of the 5' and/or 3' altera­
tions to the cellular gene.
Expression of e-ros.
Many of the cellular oncogenes are expressed during prenatal and early post­
natal development and show patterns of stage and tissue specificity unique for
each gene. However, c-mos (the cellular counterpart of the viral transforming
gene of Molony murine sarcoma virus) transcripts have yet to be identified in
normal tissues or cell lines although induction of c-mos has been reported in neo­
plastic cells resulting from a genomic rearrangement that substituted an LTR ele­
ment for 5' mos sequences (for review see Muller and Verma, 43). e-mos
sequences are capable of transforming Nlli-3T3 cells when linked to a viral LTR.
These observations lend credence to the hypothesis that transformation by the
viral gene is a result of its heightened expression. A 3.1 kb e-ros transcript has
been detected in adult muscle tissue and in kidney from chickens only after long
exposure of the Northern filters. It appears that the e-ros transcript in kidney is
preferentially degraded relative to src, and this may account for the seeming lack
of expression in this tissue. However, in all other tissues, and in several cell lines,
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e-ros transcripts are not detectable. Therefore, it is entirely possible
that the
high level of expression of viral ros in infected cells may be a causitive
factor in
effecting transformation. Alternatively, the increased stability of the viral
mes­
sage may be responsible for its neoplastic effects.
Function of cellular ros in normal cells.
The transcript detected for e-ros is 3.1 kb, and the portion of c-ros trans­
duced by UR2AV is 1.2 kb of coding sequence. There is insufficient data to specu­
late how the remaining 1.9 kb of the transcribed sequences would distribute
among the 5' and 3' ends of the gene.
Comparison of the deduced amino acid sequence of viral and cellular ros indi­
cates structural and possibly functional similarities with both the EGF and insu­
lin receptors. The transmembrane and cytoplasmic domains of the EGF receptor
appear to have been transduced by a retrovirus to form v-erbB (14, 75). The v­
fms protein product (of McDonough feline sarcoma virus), like v-erbB, is
glycosylated, membrane associated (presumably through the hydrophobic
domains of the proteins), and shares striking homology with the family of tyro­
sine protein kinases (23, 56). Recent reports (19, 56) have shown tyrosine kinase
activity to be associated with the v-erbB and v-fms protein products.
P68 has been shown to be an integral membrane protein (Ellen Garber,
unpublished), presumably due to the 29 amino acid amino-terminal hydrophobic
stretch; the protein is not glycosylated (Ellen Garber, unpublished). v-ros shares
greater homology in the conserved kinase domain with the insulin receptor than
any of the other tyrosine protein kinase-encoding oncogenes (76). Comparison of
the structural domains of the EGF and insulin receptors with v-erbB, v-fms, and
the region of cellular ros sequenced thus far leads to the tentative conclusion that
the protein product of e-ros is a member of a family of growth factor receptors
Fig. 33. Family of growth factor receptors. Cysteine-rich residues found in
the extracellular domains of the proteins are shown by hatched boxes. A heavier
solid line shows the region of the protein spanning the mem brane. The
transmem brane domain is 25 residues in length.
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(Fig. 33).
The transmembrane domain in e-ros and v-fms is 26 residues in length com­
pared to 23 for the 'EGF and insulin receptors. On the cytoplasmic side of the
mem brane, the insulin and EGF receptors have 3 basic amino acids (Arg-Lys-Arg
and Arg-Arg-Arg, respectively). v-fms is marked by Lys-Tyr-Lys-Gln-Lys and c­
ros by Gln-Arg-Trp-Lys, both of which are highly basic sequences of the kind
expected to occur at the cytoplasmic junction of the membrane domain. The
insulin and EGF receptors contain a Pro-Ser flanking the extracellular side of the
membrane; in e-ros, a Ser-Pro sequence is present. The tyrosine kinase domains
of v-fms and the EGF and insulin receptors are located 50 amino acids down­
stream of the transmembrane domain; in ros, the kinase domain begins 68 resi­
dues downstream.
The 5' domain of e-ros has not been characterized. In the EGF and isulin
receptors, the transmembrane domain is located within the middle of the protein,
and the 5' extracellular domain is marked by cysteine-rich regions. It would be
interesting to see whether this is true for cellular rose
The EGF receptor is not oncogenic, yet v-erbB has transforming ability.
Their sequences are highly conserved except for the missing 5' extracellular
domain in v-erbB, and replacement of some of the 3' cellular sequences with a
few amino acids of viral env. Perhaps truncation of the gene activates its
oncogenic potential, and this might be analagous to v-ros, which has only 7
amino acid residues upstream of the transmembrane domain before fusion with
viral gag sequences.
P6S is a gag-fusion product. It is not known whether the gag moiety is essen­
tial for transformation by rose It is conceivable that replacement of the extracel­
lular domain of the e-ros protein by ap19 (and perhaps alteration of the
carboxy-terminus) may dramatically alter the receptor's specificity of interaction
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with the growth factor.
P68 has been proposed to be capable of phosphorylating phosphatidylinositol
to phosphatidylinositol-4-phosphate (4a), resulting in an increase in diacylgly­
cerol. Diacylglycerol activates C kinase, and activation of this protein may be
linked to mitogenesis. C kinase has been strongly implicated in a receptor­
mediated cell-signalling cascade. If v-ros is an altered receptor, it is possible that
its oncogenic potential results from an acquired ability to phosphorylate, and
thus activate, components of this cascade. However, recent results from our
laboratory (Sumio Sugano and Hidesaburo Hanafusa, Mol. Cell BioI., in press)
suggests that lipid kinase activity is not intrinsic to P68, and that the previously
described phosphatidylinositol kinase activity is due to contaminating cellular
kinases.
Although the exact function of the cellular r08 protein is not known, evidence
based on the sequence of the viral and cellular genes has enabled us to detect its
structural similarity with the EGF and insulin receptors and postulate that r08 is
a member of a family of growth factor receptors.
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